Taipei Exchange - Delayed Quote TWD

General Biologicals Corporation (4117.TWO)

15.50
+0.05
+(0.32%)
At close: 2:59:54 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
251,926
251,926
264,825
370,459
551,658
Cost of Revenue
244,391
244,391
202,119
198,606
269,722
Gross Profit
7,535
7,535
62,706
171,853
281,936
Operating Expense
220,678
220,678
236,522
216,429
253,885
Operating Income
-213,143
-213,143
-173,816
-44,576
28,051
Net Non Operating Interest Income Expense
-11,030
-11,030
-9,321
-15,779
-10,513
Pretax Income
-222,114
-222,114
-187,718
-46,127
38,606
Tax Provision
-292
-292
12,129
7,690
-5,476
Net Income Common Stockholders
-220,823
-220,823
-198,834
-53,192
44,142
Diluted NI Available to Com Stockholders
-220,823
-220,823
-198,834
-53,192
44,142
Basic EPS
-3.69
--
-3.32
-0.89
0.74
Diluted EPS
-3.69
--
-3.32
-0.89
0.74
Basic Average Shares
59,843.63
--
59,889.76
59,825
59,825
Diluted Average Shares
59,843.63
--
59,889.76
59,825
59,907
Total Expenses
465,069
465,069
438,641
415,035
523,607
Net Income from Continuing & Discontinued Operation
-220,823
-220,823
-198,834
-53,192
44,142
Normalized Income
-218,186.47
-218,186.47
-201,938
-56,156
31,548.40
Interest Income
2,337
2,337
2,661
1,078
490
Interest Expense
13,367
13,367
11,982
16,857
11,003
Net Interest Income
-11,030
-11,030
-9,321
-15,779
-10,513
EBIT
-208,747
-208,747
-175,736
-29,270
49,609
EBITDA
-170,712
-170,712
-139,060
6,646
85,343
Reconciled Cost of Revenue
244,391
244,391
202,119
198,606
269,722
Reconciled Depreciation
38,035
38,035
36,676
35,916
35,734
Net Income from Continuing Operation Net Minority Interest
-220,823
-220,823
-198,834
-53,192
44,142
Total Unusual Items Excluding Goodwill
-2,640
-2,640
3,880
3,705
15,742
Total Unusual Items
-2,640
-2,640
3,880
3,705
15,742
Normalized EBITDA
-168,072
-168,072
-142,940
2,941
69,601
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3.47
-3.47
776
741
3,148.40
12/31/2021 - 10/25/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1780.TWO Allied Biotech Corporation
17.95
-0.55%
 
4166.TWO Orient Pharma Co., Ltd.
33.45
+1.36%
 
6483.TWO Original BioMedicals Co., Ltd.
12.05
+0.42%
 
6677.TWO Anxo Pharmaceutical Co., Ltd.
16.05
-1.23%
 
4132.TWO Golden Biotechnology Corporation
13.85
-1.42%
 
4172.TWO InnoPharmax Inc.
17.55
-2.23%
 
7561.TWO Bioray Biotech Co., Ltd
21.15
-0.47%
 
6539.TWO DV Biomed Co., Ltd.
81.00
+2.27%
 
6467.TWO TAHO Pharma
59.10
+3.50%
 
6621.TWO UniPharma Co., Ltd.
14.50
-0.68%